Transcatheter Tricuspid Valve-in-Valve Implantation With a Novel Balloon Expandable Myval THV.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 33737045.
- Also identified by DOI 10.1016/j.athoracsur.2021.03.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system.
Medical subject headings
- Cardiac Catheterization
- Heart Valve Prosthesis
- Heart Valve Prosthesis Implantation
- Tricuspid Valve